SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria flag Austria · Delayed Price · Currency is EUR
13.76
0.00 (0.00%)
At close: Apr 2, 2026
Market Cap2.06B -41.5%
Revenue (ttm)995.03M +4.1%
Net Income149.95M +11.1%
EPS0.99 +10.0%
Shares Outn/a
PE Ratio13.76
Forward PE14.06
Dividend0.18 (1.32%)
Ex-Dividend DateFeb 4, 2026
Volumen/a
Average Volume30
Open13.42
Previous Closen/a
Day's Range13.42 - 13.76
52-Week Range12.74 - 30.10
Betan/a
RSI48.91
Earnings DateMay 13, 2026

About VIE:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,829
Stock Exchange Vienna Stock Exchange
Ticker Symbol 1SXP

Financial Performance

In fiscal year 2025, VIE:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements